DONALD BERRY to Precision Medicine
This is a "connection" page, showing publications DONALD BERRY has written about Precision Medicine.
Connection Strength
0.961
-
Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses. Clin Cancer Res. 2014 Sep 15; 20(18):4827-36.
Score: 0.286
-
Reports from the 2010 Clinical and Translational Cancer Research Think Tank meeting: design strategies for personalized therapy trials. Clin Cancer Res. 2012 Feb 01; 18(3):638-44.
Score: 0.242
-
Adaptive clinical trials in oncology. Nat Rev Clin Oncol. 2011 Nov 08; 9(4):199-207.
Score: 0.238
-
The Signature Program: Bringing the Protocol to the Patient. Clin Pharmacol Ther. 2015 Aug; 98(2):124-6.
Score: 0.076
-
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative. Clin Cancer Res. 2012 Nov 15; 18(22):6373-83.
Score: 0.063
-
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes. Nat Commun. 2018 03 23; 9(1):1219.
Score: 0.023
-
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies. J Natl Compr Canc Netw. 2014 Nov; 12(11):1629-49.
Score: 0.018
-
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol. 2011 Jul 10; 29(20):2787-94.
Score: 0.014